SNC-Lavalin Group Inc. (TSE:ATR – Free Report) – Investment analysts at Raymond James cut their Q1 2025 earnings estimates for SNC-Lavalin Group in a research report issued on Friday, March 14th. Raymond James analyst F. Bastien now expects that the company will post earnings per share of $0.54 for the quarter, down from their previous forecast of $0.57. Raymond James also issued estimates for SNC-Lavalin Group’s Q2 2025 earnings at $0.65 EPS, Q4 2025 earnings at $0.82 EPS, Q1 2026 earnings at $0.70 EPS, Q2 2026 earnings at $0.84 EPS, Q3 2026 earnings at $1.01 EPS and Q4 2026 earnings at $0.85 EPS.
Separately, Stifel Canada raised SNC-Lavalin Group to a “strong-buy” rating in a report on Tuesday, February 4th.
SNC-Lavalin Group Stock Performance
SNC-Lavalin Group Company Profile
AptarGroup, Inc provides a range of dispensing, sealing, and material science solutions primarily for the beauty, personal care, home care, prescription drug, consumer health care, injectable, and food and beverage markets. The company operates through three segments: Pharma, Beauty + Home, and Food + Beverage.
Read More
- Five stocks we like better than SNC-Lavalin Group
- What to Know About Investing in Penny Stocks
- Can TikTok Stock Picks Really Make You Rich?
- With Risk Tolerance, One Size Does Not Fit All
- The “Quality” Rotation: Back to Basics Investing
- What Are Dividend Champions? How to Invest in the Champions
- Occidental Petroleum: 4 Reasons to Love These Prices
Receive News & Ratings for SNC-Lavalin Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SNC-Lavalin Group and related companies with MarketBeat.com's FREE daily email newsletter.
